Skip to content

An Exploratory Investigation of the Use of Drive App to Measure Sleep Parameters in Users of CPAP Therapy

An Exploratory Investigation of the Use of Drive App to Measure Sleep Parameters in Users of CPAP Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04500327
Enrollment
12
Registered
2020-08-05
Start date
2020-06-25
Completion date
2021-06-30
Last updated
2020-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

The purpose of this study is to evaluate the usability and suitability of the Drive app (app under test) to measure sleep parameters during CPAP use. This is a prospective, non-randomized, single arm exploratory study without blinding. Current users of CPAP therapy will be recruited for this study and will be provided with a smartphone (app under test installed) and a non-contact motion sensor in their home environment. These devices will measure sleep metrics such as sleep stages and breathing metrics that may be associated with sleep disordered breathing. Usage and setup instructions will be provided for the study. Participants will contribute up to 7 overnight recordings in the home environment and will complete daily questionnaires detailing their experience. The study may be completed in two distinct phases, with an analysis performed after each phase. Each phase is expected to last up to six weeks with the overall study duration taking up to 12 months.

Detailed description

The study may be completed in two distinct phases, with an analysis performed after each phase. Phase 1 (Exploratory): A minimum of 10 and up to 12 participants will be recruited to identify any issues in using the app when used in conjunction with CPAP therapy (e.g. missed signals, inappropriate classification of breathing signals). Phase 2 (Iterative Updates): Where changes to the algorithm or user interface are required, an additional 30 and up to 35 participants may be tested to provide design confidence. Conversely, if substantial issues are experienced and the time and effort required to address the issues is sufficiently large, the study may terminate before completion of phase 2. Each phase is expected to last up to six weeks with the overall study duration taking up to 12 months. Participants will be required to visit ResMed twice. The first visit will involve briefing of the study, consent form signatures, briefing on trial equipment and setup/usage instructions. The second (last) visit will involve going through the daily questionnaires with participants, collecting trial equipment and providing reimbursement for the study.

Interventions

OTHERDrive app

The Drive app will be used to monitor sleep metrics for users of CPAP therapy.

DEVICENon contact motion sensor

The non contact motion sensor will be used as a reference to the Drive app i.e. Drive app overnight recordings will be compared to the non contact motion sensor overnight recordings.

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants willing to give written informed consent * Participants who can read and comprehend English * Participants who ≥ 18 years of age * Participants established on CPAP therapy for the treatment of OSA for ≥ 6 months * Participants who are able to set up the trial devices (ideally on a bedside table) with the following criteria: * Trial devices must be 10 cm higher than the mattress * Approx. 40 cm from the person's chest in bed * Participants that have access to WI-FI in their home environment * Participants who can trial the device for up to 7 nights * \*Participants who have been compliant (average of ≥4 hours of usage) to therapy for up to 7 nights of use * Note: the most recent consecutive 7 nights within the last 30 days

Exclusion criteria

* Participants using Bilevel flow generators * Participants who are or may be pregnant, breastfeeding or within 6 weeks postpartum (which are known to cause significant sleep disruption) * Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury. * Participants believed to be unsuitable for inclusion by the researcher * \*Participants using one of the following devices or Apps during the research period, or any other sleep tracking devices: SPlus, SleepScore app, SleepScore Max. * Note: If the participant uses the devices or apps above and they agree to delete/not use them during study period, they can be included in the study.

Design outcomes

Primary

MeasureTime frameDescription
Identify any failures when using the Drive app for users of CPAP therapy12 months (includes Phase 1 and Phase 2 and interim data analysis)This will be based on: 1. Subjective data from daily questionnaires sent out to participants 2. Comparison between Drive app data with the non contact motion sensor and CPAP data The questionnaire has yes/no questions and a likert scale (from 0-10) that participants fill in to indicate how representative each nights sleep hypnogram is. For e.g. if the participant was awake between 12am-1am but the app reports that the subject is in deep sleep, this will be captured in the questionnaire. Metrics including accuracy, correlation, total cohens kappa will be used for each signal recorded by the app which will be used to compare to the data from the reference devices.

Secondary

MeasureTime frameDescription
Evaluate usability of the Drive app12 months (includes Phase 1 and Phase 2 and interim data analysis)This will be based on subjective data from daily questionnaires sent out to participants. This data will be captured from comments by the participants in the daily questionnaires.
Compare subjective sleep quality data with data generated on the app.12 months (includes Phase 1 and Phase 2 and interim data analysis)This will be based on subjective data from daily questionnaires sent out to participants. The questionnaire has yes/no questions and a likert scale (from 0-10) that participants fill in to indicate how representative each nights sleep hypnogram is. For e.g. if the participant was awake between 12am-1am but the app reports that the subject is in deep sleep, this will be captured in the questionnaire.
Compare the Drive app sleep data to data from the reference devices.12 months (includes Phase 1 and Phase 2 and interim data analysis)Analyses will be performed to compare the Drive app data with the non contact motion sensor and CPAP device. Metrics including accuracy, correlation, total cohens kappa will be used for each signal recorded by the app which will be used to compare to the data from the reference devices.

Countries

Australia

Contacts

Primary ContactNeha Banodkar
neha.banodkar@resmed.com.au(02) 8884 2656

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026